Coagulation factor XIII Val34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage

Cerebrovascular Diseases

Volumn 19, Issue 3, 2005, Pages 165-170

  Slowik, Agnieszka ^a   Dziedzic, Tomasz ^a   Pera, Joanna ^a   Figlewicz, Denise A ^b   Szczudlik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Factor XIII polymorphism; Genetics; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR; LEUCINE; VALINE; BLOOD CLOTTING FACTOR 13;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; VASCULAR DISEASE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR;

AGED; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; FACTOR XIII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 17444379318     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083251     Document Type: Article

References (28)

1. Ichinose A: Physiology and regulation of factor XIII. Thromb Haemost 2001;86:57-65.
2. Kangsadalampai S, Board PG: The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 1998;92:2766-2770.
3. Kohler HP, Ariens RA, Whitaker P, Grant PJ: A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity (letter). Thromb Haemost 1998;80:704.
4. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ: The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000;96:988-995.
5. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ: Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Heamost 1998;79:8-13.
6. Wartiovaara U, Perola M, Mikkola H, Totterman K, Savolainen V, Penttila A, Grant PJ, Tikkanen MJ, Vartiainen E, Karhunen PJ, Peltonen L, Palotie A: Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 1999;142:295-300.
7. Franco RF, Reitsma PH, Lourenco D, Maffei FH, Morelli V, Tavella MH, Araujo AG, Piccinato CE, Zago MA: Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis. Thromb Haemost 1999;81: 676-679.
8. Weger M, Renner W, Stanger O, Schmut O, Deutschmann H, Wascher TC, Haas A: Role of factor XIII Val34Leu polymorphism in retinal artery occlusion. Stroke 2001;32:2759-2761.
9. Elbaz A, Poirier O, Canaple S, Chedru F, Cambien F, Amarenco P: The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000;95:586-591.
10. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ: Factor XIII Val 34 Leu: A novel association with primary intracerebral hemorrhage. Stroke 1998;29:813-816.
11. Lim BCB, Ariens RAS, Carter AM, Weisel JW, Grant PJ: Genetic regulation of fibrin structure and function: Complex gene-environment interactions may modulate vascular risk. Lancet 2003;361:1424-1431.
12. Hantano S: Experience from multicentre stroke register: A preliminary report. Bull World Health Organ 1976;54:541-553.
13. Adams HP, Bendixen BH, Kappelle LJ, and the TOAST Investigators: Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
14. Alberti KG, Zimmet PZ: Definition, diagnosis, and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus - Provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
15. Gemmati D, Serino ML, Ongaro A, Tognazzo S, Moratelli S, Resca R, Moretti M, Scapoli GL: A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 2001;67:183-188.
16. Corral J, Gonzalez-Conejero R, Iniesta JA, Rivera J, Martinez C, Vicente V: The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Hematologica 2000; 85:293-297.
17. Endler G, Funk M, Haering D, Lalouschek W, Lang W, Mirafzal M, Wagner O, Mannhalter C: Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol 2003;120:310-314.
18. Reiner AP, Frank MB, Schwartz SM, Linenberger ML, Longstreth WT Jr, Teramura G, Rosendaal FR, Psaty BM, Siscovick DS: Coagulation factor XIII polymorphism and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol 2002; 116:376-382.
19. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS: Evaluating the genetic component of ischemic stroke subtypes: A family history study. Stroke 2003;34:1364-1369.
20. Attie-Castro FA, Zago MA, Lavinha J, Elion J, Rodriguez-Delfin L, Guerreiro JF, Franco RF: Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 2000;84:601-603.
21. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T: Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health 2003;57: 730-733.
22. Corral J, Iniesta JA, Gonzalez-Conejero R, Villalon M, Vicente V: Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 2001;97:2979-2982.
23. Cho KH, Kim BC, Kim MK, Shin BA: No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population. J Korean Med Sci 2002;17:249-253.
24. Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF: Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke 1998;29: 913-917.
25. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MMB: Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002;33:21-25.
26. Eguchi K, Kario K, Shimada K: Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke 2003;34: 2471-2474.
27. Uehara T, Tabuchi M, Mori E: Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke 1999;30:378-382.
28. Bernick C, Kuller L, Dulberg C, Longstreth WT Jr, Manolio T, Beauchamp N, Price T, Cardiovascular Health Study Collaborative Reseach Group: Silent MRI infarcts and the risk of future stroke: The cardiovascular health study. Neurology 2001;57:1222-1229.